Platelet and Soluble Glycoprotein VI - Novel Applications in Diagnosis and Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|12|12|1821-1830

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.12, 2011-11, pp. : 1821-1830

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lack of Platelet Activation Reflected by Circulating Soluble Glycoprotein V in Pre-eclampsia

By Acar K   Sucak A   Beyazit Y   Genc G   Haznedaroglu IC   Aksu S   Danisman N  

The Journal of International Medical Research, Vol. 35, Iss. 5, 2007-09 ,pp. : 704-708

Field House Publishing

Access to resources Recommend Favorite

Pharmacological properties of YM-57029, a novel platelet glycoprotein IIb/IIIa antagonist

By Moritani Y.   Sato K.   Shigenaga T.   Hisamichi N.   Ichihara M.   Akamatsu S.   Suzuki K.-i.   Nii T.   Kaku S.   Kawasaki T.   Matsumoto Y.   Inagaki O.   Tomioka K.   Yanagisawa I.  

European Journal of Pharmacology, Vol. 439, Iss. 1, 2002-03 ,pp. : 43-52

Elsevier

Access to resources Recommend Favorite

Current Dendrimer Applications in Cancer Diagnosis and Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 14, 2008-09 ,pp. : 1165-1179

Bentham Science Publishers

Access to resources Recommend Favorite

Antiaggregatory, antithrombotic effects of MS-180, a novel platelet glycoprotein II b /III a receptor antagonist

By Banno H.   Kawazura H.   Yutaka T.   Sakuma N.   Kitamori T.   Hosoya J.   Kibayashi K.   Yamashita H.   Umemura K.   Nakashima M.  

European Journal of Pharmacology, Vol. 367, Iss. 2, 1999-02 ,pp. : 275-282

Elsevier

Access to resources Recommend Favorite

Recombinant antibodies: a novel approach to cancer diagnosis and therapy

By Hudson P.J.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 6, 2000-06 ,pp. : 1231-1242

Informa Healthcare

Access to resources Recommend Favorite